questionsmedicales.fr
Enzymes et coenzymes
Enzymes
Hydrolases
Ureohydrolases
Ureohydrolases : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Déficience enzymatique
Urée
Ammoniac
Tests enzymatiques
Biochimie clinique
Ureohydrolases
Symptômes neurologiques
Fatigue
Confusion
Tests génétiques
Mutations
Déficience enzymatique
Antécédents médicaux
Troubles métaboliques
Hérédité
Symptômes
5
Nausées
Vomissements
Troubles de la conscience
Hyperammoniémie
Céphalées
Convulsions
Nourrissons
Enfants
Symptômes
Irritabilité
Léthargie
Troubles de l'alimentation
Conditions médicales
Symptômes
Déficience enzymatique
Prévention
5
Prévention
Dépistage
Risques
Conseils diététiques
Accumulation d'urée
Prévention
Dépistage néonatal
Troubles métaboliques
Prévention
Antécédents familiaux
Suivi médical
Prévention
Vaccinations
Prévention
Troubles
Traitements
5
Restriction protéique
Suppléments
Arginine
Médicaments
Ammoniac
Gestion des symptômes
Dialyse
Ammoniac
Traitement
Thérapie nutritionnelle
Niveaux d'urée
Gestion
Thérapie génique
Traitements expérimentaux
Recherche
Complications
5
Hyperammoniémie
Lésions cérébrales
Complications
Troubles du comportement
Accumulation d'ammoniac
Complications
Qualité de vie
Complications
Soins constants
Complications
Traitement
Réversibilité
Facteurs de risque
5
Facteurs de risque
Antécédents familiaux
Maladies métaboliques
Alimentation
Protéines
Facteurs de risque
Infections
Symptômes
Ammoniac
Facteurs environnementaux
Pollution
Métabolisme
Médicaments
Métabolisme
Urée
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Ureohydrolases : Questions médicales les plus fréquentes",
"headline": "Ureohydrolases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Ureohydrolases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-02",
"dateModified": "2025-02-27",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Ureohydrolases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Hydrolases",
"url": "https://questionsmedicales.fr/mesh/D006867",
"about": {
"@type": "MedicalCondition",
"name": "Hydrolases",
"code": {
"@type": "MedicalCode",
"code": "D006867",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Arginase",
"alternateName": "Arginase",
"url": "https://questionsmedicales.fr/mesh/D001119",
"about": {
"@type": "MedicalCondition",
"name": "Arginase",
"code": {
"@type": "MedicalCode",
"code": "D001119",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.913.292"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Ureohydrolases",
"alternateName": "Ureohydrolases",
"code": {
"@type": "MedicalCode",
"code": "D014512",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "M Sinn",
"url": "https://questionsmedicales.fr/author/M%20Sinn",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of Konstanz, Konstanz, Germany. malte.sinn@uni-konstanz.de."
}
},
{
"@type": "Person",
"name": "L Riede",
"url": "https://questionsmedicales.fr/author/L%20Riede",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of Konstanz, Konstanz, Germany."
}
},
{
"@type": "Person",
"name": "J R Fleming",
"url": "https://questionsmedicales.fr/author/J%20R%20Fleming",
"affiliation": {
"@type": "Organization",
"name": "Department of Biology, University of Konstanz, Konstanz, Germany."
}
},
{
"@type": "Person",
"name": "D Funck",
"url": "https://questionsmedicales.fr/author/D%20Funck",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of Konstanz, Konstanz, Germany."
}
},
{
"@type": "Person",
"name": "H Lutz",
"url": "https://questionsmedicales.fr/author/H%20Lutz",
"affiliation": {
"@type": "Organization",
"name": "Department of Biology, University of Konstanz, Konstanz, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Personalized oncology, ethics and adherence to NCCN guidelines.",
"datePublished": "2024-10-14",
"url": "https://questionsmedicales.fr/article/39400758",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12032-024-02500-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Guideline adherence in ovarian cancer for surgical staging in the Netherlands.",
"datePublished": "2022-12-05",
"url": "https://questionsmedicales.fr/article/36270772",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/ijgc-2022-003666"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Dutch guideline to prevent perioperative pulmonal complications: how is the adherence?]",
"datePublished": "2022-10-20",
"url": "https://questionsmedicales.fr/article/36300494",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": null
}
},
{
"@type": "ScholarlyArticle",
"name": "Guideline Adherence and Practice Patterns in the Management of Medullary Thyroid Cancer.",
"datePublished": "2022-09-30",
"url": "https://questionsmedicales.fr/article/36191377",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jss.2022.08.039"
}
},
{
"@type": "ScholarlyArticle",
"name": "Adherence to national guidelines for colorectal, breast, and cervical cancer screenings in Japanese workplaces: a survey-based classification of enterprises' practices into \"overscreening,\" \"underscreening,\" and \"guideline-adherence screening\".",
"datePublished": "2024-08-15",
"url": "https://questionsmedicales.fr/article/39148101",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12889-024-19775-1"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Enzymes et coenzymes",
"item": "https://questionsmedicales.fr/mesh/D045762"
},
{
"@type": "ListItem",
"position": 3,
"name": "Enzymes",
"item": "https://questionsmedicales.fr/mesh/D004798"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hydrolases",
"item": "https://questionsmedicales.fr/mesh/D006867"
},
{
"@type": "ListItem",
"position": 5,
"name": "Ureohydrolases",
"item": "https://questionsmedicales.fr/mesh/D014512"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Ureohydrolases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Ureohydrolases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Ureohydrolases",
"description": "Comment diagnostiquer une déficience en ureohydrolases ?\nQuels tests sont utilisés pour évaluer l'activité des ureohydrolases ?\nQuels symptômes indiquent un problème avec les ureohydrolases ?\nLes tests génétiques sont-ils utiles pour les ureohydrolases ?\nComment l'historique médical aide-t-il au diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D014512?mesh_terms=Guideline+Adherence#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Ureohydrolases",
"description": "Quels sont les symptômes d'une accumulation d'urée ?\nComment se manifeste une hyperammoniémie ?\nLes symptômes varient-ils selon l'âge ?\nQuels signes cliniques sont associés à une déficience en ureohydrolases ?\nPeut-on avoir des symptômes sans déficience enzymatique ?",
"url": "https://questionsmedicales.fr/mesh/D014512?mesh_terms=Guideline+Adherence#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Ureohydrolases",
"description": "Peut-on prévenir les troubles liés aux ureohydrolases ?\nLes conseils diététiques peuvent-ils prévenir ces troubles ?\nLe dépistage néonatal est-il recommandé ?\nLes antécédents familiaux influencent-ils la prévention ?\nLes vaccinations ont-elles un rôle dans la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D014512?mesh_terms=Guideline+Adherence#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Ureohydrolases",
"description": "Quel est le traitement principal pour les troubles liés aux ureohydrolases ?\nLes médicaments peuvent-ils aider à gérer les symptômes ?\nLa dialyse est-elle une option de traitement ?\nLes thérapies nutritionnelles sont-elles efficaces ?\nY a-t-il des traitements expérimentaux pour ces troubles ?",
"url": "https://questionsmedicales.fr/mesh/D014512?mesh_terms=Guideline+Adherence#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Ureohydrolases",
"description": "Quelles complications peuvent survenir avec une hyperammoniémie ?\nLes troubles du comportement sont-ils une complication ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications sont-elles réversibles ?\nLes complications peuvent-elles survenir à tout âge ?",
"url": "https://questionsmedicales.fr/mesh/D014512?mesh_terms=Guideline+Adherence#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Ureohydrolases",
"description": "Quels sont les facteurs de risque pour les troubles des ureohydrolases ?\nL'alimentation joue-t-elle un rôle dans les facteurs de risque ?\nLes infections peuvent-elles aggraver les troubles ?\nLes facteurs environnementaux influencent-ils ces troubles ?\nLes médicaments peuvent-ils être un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D014512?mesh_terms=Guideline+Adherence#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en ureohydrolases ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et urinaires mesurant les niveaux d'urée et d'ammoniac sont effectués."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'activité des ureohydrolases ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests enzymatiques spécifiques et des analyses biochimiques sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème avec les ureohydrolases ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la confusion, la fatigue et des troubles neurologiques peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles pour les ureohydrolases ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent identifier des mutations génétiques liées à des déficiences enzymatiques."
}
},
{
"@type": "Question",
"name": "Comment l'historique médical aide-t-il au diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical peut révéler des antécédents familiaux de troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une accumulation d'urée ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des nausées, des vomissements, et des troubles de la conscience."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une hyperammoniémie ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se manifeste par des troubles neurologiques, des céphalées et des convulsions."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent être plus graves chez les nourrissons et les jeunes enfants."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont associés à une déficience en ureohydrolases ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme l'irritabilité, la léthargie et des troubles de l'alimentation peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans déficience enzymatique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, d'autres conditions médicales peuvent provoquer des symptômes similaires."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les troubles liés aux ureohydrolases ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est difficile, mais un dépistage précoce peut aider à gérer les risques."
}
},
{
"@type": "Question",
"name": "Les conseils diététiques peuvent-ils prévenir ces troubles ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des conseils diététiques peuvent réduire le risque d'accumulation d'urée."
}
},
{
"@type": "Question",
"name": "Le dépistage néonatal est-il recommandé ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage néonatal peut identifier les troubles métaboliques précocement."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de troubles peuvent justifier un suivi médical accru."
}
},
{
"@type": "Question",
"name": "Les vaccinations ont-elles un rôle dans la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les vaccinations ne préviennent pas directement les troubles liés aux ureohydrolases."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour les troubles liés aux ureohydrolases ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est une restriction protéique et des suppléments d'arginine."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider à gérer les symptômes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des médicaments peuvent être prescrits pour réduire les niveaux d'ammoniac."
}
},
{
"@type": "Question",
"name": "La dialyse est-elle une option de traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la dialyse peut être utilisée pour éliminer l'excès d'ammoniac dans les cas graves."
}
},
{
"@type": "Question",
"name": "Les thérapies nutritionnelles sont-elles efficaces ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une thérapie nutritionnelle adaptée peut aider à gérer les niveaux d'urée."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux pour ces troubles ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements expérimentaux, comme la thérapie génique, sont en cours d'étude."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une hyperammoniémie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications graves incluent des lésions cérébrales et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les troubles du comportement sont-ils une complication ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles du comportement peuvent survenir en raison de l'accumulation d'ammoniac."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent gravement affecter la qualité de vie et nécessiter des soins constants."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié, d'autres non."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles survenir à tout âge ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent survenir à tout âge, mais sont plus fréquentes chez les jeunes."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les troubles des ureohydrolases ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des maladies métaboliques et des régimes inappropriés."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle dans les facteurs de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en protéines peut augmenter le risque d'accumulation d'urée."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles aggraver les troubles ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections peuvent exacerber les symptômes et augmenter les niveaux d'ammoniac."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux influencent-ils ces troubles ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des facteurs environnementaux comme la pollution peuvent affecter le métabolisme."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils être un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent interférer avec le métabolisme de l'urée et des enzymes."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 27/02/2025
Contenu vérifié selon les dernières recommandations médicales
1 publication dans cette catégorie
Affiliations :
Department of Chemistry, University of Konstanz, Konstanz, Germany. malte.sinn@uni-konstanz.de.
Publications dans "Ureohydrolases" :
1 publication dans cette catégorie
Affiliations :
Department of Chemistry, University of Konstanz, Konstanz, Germany.
Publications dans "Ureohydrolases" :
1 publication dans cette catégorie
Affiliations :
Department of Biology, University of Konstanz, Konstanz, Germany.
Publications dans "Ureohydrolases" :
1 publication dans cette catégorie
Affiliations :
Department of Chemistry, University of Konstanz, Konstanz, Germany.
Publications dans "Ureohydrolases" :
1 publication dans cette catégorie
Affiliations :
Department of Biology, University of Konstanz, Konstanz, Germany.
Publications dans "Ureohydrolases" :
1 publication dans cette catégorie
Affiliations :
Department of Biology, University of Konstanz, Konstanz, Germany.
Publications dans "Ureohydrolases" :
1 publication dans cette catégorie
Affiliations :
Department of Biology, University of Konstanz, Konstanz, Germany.
Konstanz Research School Chemical Biology (KoRS-CB), University of Konstanz, Konstanz, Germany.
Publications dans "Ureohydrolases" :
1 publication dans cette catégorie
Affiliations :
Department of Chemistry, University of Konstanz, Konstanz, Germany. joerg.hartig@uni-konstanz.de.
Konstanz Research School Chemical Biology (KoRS-CB), University of Konstanz, Konstanz, Germany. joerg.hartig@uni-konstanz.de.
Publications dans "Ureohydrolases" :
Successful personalized oncology today depends on clinicians taking advantage of the extensive, evidence-based information provided by the National Comprehensive Cancer Network (NCCN) Guidelines, whic...
Previous studies have shown low adherence to surgical staging guidelines in patients with clinical early-stage ovarian carcinoma. The aim of this study was to identify guideline adherence for surgical...
Patients with ovarian cancer and surgical staging registered in the Dutch Gynecological Oncology Audit between January 1, 2015 and December 31, 2019 in the Netherlands were included. Complete surgical...
604 patients underwent surgical staging, 365 (60%) underwent an incomplete staging procedure, 295 (81%) were registered with early-stage disease (International Federation of Gynecology and Obstetrics ...
Guideline adherence for staging was lower than expected and validation of data gave additional insights into the reasons that were contributing to incomplete surgical staging. Moreover, this analysis ...
Patients with a history of chronic obstructive pulmonary disease (COPD) or asthma undergoing surgery are at risk for developing postoperative pulmonary complications, associated with morbidity and mor...
Patients with a history of asthma and/or COPD who underwent non-thoracic surgery between January 2017 and July 2018 in our hospital, were included. Primary outcome was perioperative administration of ...
1,623 patients qualified for a preventative treatment. Overall, 653 patients (40%) received treatment according to protocol. The other 970 patients received no treatment (79%), another corticosteroid ...
The current guideline for prevention of postoperative pulmonary complications has not been implemented thoroughly at our hospital. The lack of adherence appears to be caused by lack in clarity in clin...
Little is known about nationwide practice patterns for the management medullary thyroid cancer (MTC) in relation to the 2015 American Thyroid Association guidelines and their impact on survival....
Using the Surveillance, Epidemiology, and End Results Program database (2000-2018), MTC treatment patterns were evaluated in terms of adherence to the 2015 American Thyroid Association guidelines acro...
A total of 3332 patients with MTC were identified. Of which, 53.8%, 33.2%, and 11.4% of patients had localized, regional, and distant disease, respectively. In patients with locoregional disease, the ...
The rate of guideline-concordant surgery for locoregional MTC increased after guideline publication in 2015, with an observed prolongment in OS and DSS. Chemotherapy use among patients with distant di...
Workplace cancer screening programs are determined as part of an employee's benefits package and health checkups are perceived positively. However, the current status of workplace cancer screening pro...
A cross-sectional study design was employed. Data were obtained from a survey conducted by the "Corporate Action to Promote Cancer Control" between November and December 2022 among registered partner ...
The guideline-adherence rates for colorectal, breast, and cervical cancer screenings in the workplace were 12.7%, 3.0%, and 8.8%, respectively. Enterprises had lower adherence to screening guidelines ...
Adherence to national guidelines for colorectal, breast, and cervical cancer screenings in the workplace was suboptimal among Japanese enterprises. Therefore, appropriate cancer screening measures and...
Despite the availability of evidence-based inflammatory bowel disease (IBD) guidelines, suboptimal care persists. There is little published research assessing barriers to IBD guideline adherence....
To identify barriers to IBD guideline adherence including gastroenterologists' knowledge and attitudes towards guidelines....
An online cross-sectional survey of 824 Australian gastroenterologists was conducted from April to August 2018, with 198 (24%) responses. A novel survey was developed that was informed by the theoreti...
Confidence in guideline recommendations was high; however, referral to them was low. The European Crohn's and Colitis Organisation guidelines were referred to most commonly (43.6%). In multivariate an...
Although gastroenterologists have high confidence in guidelines, they use them infrequently, primarily due to specifics being difficult to remember and lack of time. Self-reported confidence in an are...
Thromboembolic events are a common risk in adults with atrial fibrillation, those with previous cerebrovascular accidents and undergoing emergency or elective surgeries. The widespread availability of...
To improve the management of cancer related pain, the National Comprehensive Cancer Network (NCCN) publishes the Adult Cancer Pain guideline on an annual basis. However, a large majority of oncology p...
The spleen is responsible for blood filtration and mounting an immune response against pathogens. In some people the spleen must be surgically removed because of traumatic events or oncological and he...
Traumatic brain injury (TBI) is a leading cause of death and morbidity worldwide. Evidence-based guidelines for managing severe TBI have been available for over 25 years. However, adherence to guideli...
A structured literature search was conducted using the MEDLINE...
Nine cohort studies were identified that fulfilled the inclusion criteria and answered the clinical question. A review of these papers was conducted....
Mortality after severe TBI improves with increasing adherence to evidence-based guidelines in both adults and children. The evidence also suggests that compliance with guideline recommendations result...